3513 completed, 651 terminated, 577 unknown, 548 recruiting. 5925 Phase 3, 1031 Phase 2.
Follow Nervous System Diseases: new trials by email Literature Review of Nervous System Diseases trials Research Report on Nervous System Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Acetyl Salicylic Acid (ASA), Placebo - Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS) | Phase 3 | Not yet recruiting | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 120 | 2027-10-01 | 2026-10-30 |
| GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) GV1001 Placebo, GV1001 1.12mg - Moderate to Severe Alzheimer's Disease | Phase 3 | Not yet recruiting | Samsung Pharmaceutical Co., Ltd. | 750 | 2027-07-01 | 2026-06-10 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Fenix Innovation Group | 40 | 2027-07-01 | 2026-09-09 |
| Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study Tricaprilin, Placebo - Alzheimer Disease | Phase 3 | Not yet recruiting | Cerecin | 535 | 2027-07-01 | 2026-10-30 |
| Valproic AcId for Traumatic BRAin INjury Trial Valproic Acid (VPA), Standard of care treatment + normal saline - Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury | Phase 2 / Phase 3 | Not yet recruiting | Northwestern University | 432 | 2027-05-01 | 2026-11-05 |
| Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia | Phase 2 / Phase 3 | Not yet recruiting | UMC Utrecht | 162 | 2027-04-01 | 2026-09-21 |
| Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion Stroke Within 4.5-24 Hours Tenecteplase (rhTNK-tPA) (0.25 mg/kg, to maximum of 25mg) - Acute Ischemic Stroke, Large Vessel Occlusion | Phase 3 | Not yet recruiting | Fujian Medical University Union Hospital | 1266 | 2027-04-01 | 2026-11-03 |
| A Study to Investigate Long-term Safety and Tolerability of Frexalimab in Participants With Multiple Sclerosis Frexalimab, Frexalimab Placebo, Teriflunomide - Multiple Sclerosis | Phase 3 | Not yet recruiting | Sanofi | 2500 | 2027-02-15 | 2026-11-12 |
| Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency LUM-201 - Growth Hormone Deficiency (GHD) | Phase 3 | Not yet recruiting | Lumos Pharma | 150 | 2027-02-01 | 2026-07-08 |
| Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2 SP-102, Placebo, Dexamethasone Sodium Phosphate 10 MG/ML - Lumbosacral Radicular Pain | Phase 3 | Not yet recruiting | Semnur Pharmaceuticals, Inc. | 755 | 2027-02-01 | 2026-09-09 |
| Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers Immediate ART Initiation, Delayed ART Initiation, 10-Week Fluconazole - Cryptococcal Antigenemia, HIV-1-infection | Phase 3 | Not yet recruiting | University of Minnesota | 505 | 2027-01-05 | 2026-09-03 |
| Dexmedetomidine for Invasive Ventilation In the NEOnate Dexmedetomidine Injectable Solution, Glucose 5% Injectable Solution - Invasive Ventilation, Infant Pain | Phase 2 / Phase 3 | Not yet recruiting | Centre Hospitalier Intercommunal Creteil | 246 | 2027-01-01 | 2026-08-26 |
| Safety of F14 Following Total Knee Replacement F14 (sustained release celecoxib) - Analgesia | Phase 2 / Phase 3 | Suspended | Arthritis Innovation Corporation | 100 | 2027-01-01 | 2026-06-05 |
| A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P) ONO-2808, Placebo - Multiple System Atrophy, Parkinson Variant | Phase 3 | Not yet recruiting | Ono Pharmaceutical Co., Ltd. | 486 | 2027-01-01 | 2026-09-17 |
| Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant Intravenous tenecteplase (TNK), Placebo - Acute Ischemic Stroke | Phase 3 | Not yet recruiting | Hackensack Meridian Health | 660 | 2027-01-01 | 2026-06-02 |
| A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PD Botulinum toxin A, bilateral medial rectus recession - Esotropia | Phase 3 | Not yet recruiting | Jaeb Center for Health Research | 244 | 2027-01-01 | 2026-04-06 |
| A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis Arbaclofen, Placebo - Spasticity | Phase 3 | Not yet recruiting | RVL Pharmaceuticals, Inc. | 442 | 2027-01-01 | 2025-12-03 |
| CiLostAzol for pReventIon of Recurrent sTroke in Africa Cilostazol 100 mg - Stroke | Phase 3 | Not yet recruiting | Northern California Institute of Research and Education | 1100 | 2027-01-01 | 2026-11-12 |
| A Multicenter, Open-label, Randomized, Non-inferiority Clinical Trial With Blinded Endpoint Assessment of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Injection - Acute Ischemic Stroke | Phase 2 / Phase 3 | Not yet recruiting | Xinqiao Hospital of Chongqing | 1192 | 2026-12-19 | 2026-11-06 |
Showing 20 of 5925. Sign in to see all of them.
Stroke (411) · Alzheimer Disease (346) · Ischemic Stroke (328) · Parkinson Disease (289) · Epilepsy (262) · Agnosia (254) · Migraine Disorders (243) · Multiple Sclerosis (239) · Pain (193) · Sleep Initiation and Maintenance Disorders (169) · Seizures (163) · Brain Neoplasms (149) · Dementia (138) · Poliomyelitis (101) · Sleep Apnea, Obstructive (99)
Central Nervous System Diseases (3353) · Brain Diseases (2894) · Pathological Conditions, Signs and Symptoms (2283) · Signs and Symptoms (1776) · Neurologic Manifestations (1711) · Neurodegenerative Diseases (1047) · Mental Disorders (1042) · Cardiovascular Diseases (1002) · Vascular Diseases (999) · Neuromuscular Diseases (946) · Cerebrovascular Disorders (864) · Pathologic Processes (764) · Neurobehavioral Manifestations (686) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (646)
Sodium Chloride (102) · Saline Solution (97) · Pregabalin (82) · Aspirin (79) · Botulinum Toxins, Type A (70) · Dexmedetomidine (64) · Levetiracetam (54) · Radiotherapy (48) · Tenecteplase (47) · Clopidogrel (46) · Topiramate (46) · Dexamethasone (43) · Ketamine (39) · Gabapentin (38) · Lacosamide (36)
Pfizer (103) · GlaxoSmithKline (98) · Novartis Pharmaceuticals (93) · Assistance Publique - Hôpitaux de Paris (84) · Eli Lilly and Company (66) · Sanofi (63) · UCB Pharma (63) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (61) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (58) · Biogen (56) · Sanofi Pasteur, a Sanofi Company (52) · Jazz Pharmaceuticals (47) · Hoffmann-La Roche (45) · Beijing Tiantan Hospital (42) · Merck Sharp & Dohme LLC (37)
United States (2598) · Canada (1039) · France (1000) · Germany (978) · United Kingdom (854) · Spain (851) · Italy (791) · Poland (648) · Australia (613) · China (604) · Belgium (499) · Netherlands (488) · Japan (470) · Czechia (415) · Russia (363)
PMID 31867054, PMID 39498781, PMID 18190818, PMID 12807523, PMID 40603145, PMID 20451898, PMID 11914403, PMID 2375765, PMID 26899665, PMID 33825230, PMID 36700520, PMID 22108357, PMID 34218211, PMID 33461041, PMID 34022170, PMID 34487721, PMID 34515113, PMID 35224730, PMID 37870112, PMID 38557959, PMID 39800465, PMID 39982105, PMID 8984084, PMID 16731270, PMID 21899409, PMID 25475413, PMID 25823975, PMID 26120369, PMID 26402769, PMID 26694975, PMID 27448285, PMID 27611736, PMID 27733070, PMID 30936738, PMID 31284771, PMID 31926466, PMID 33023488, PMID 33189083, PMID 33263359, PMID 33395098, PMID 34383289, PMID 35285519, PMID 35305920, PMID 35978286, PMID 36449262, PMID 37059702, PMID 37460385, PMID 37652990, PMID 37796657, PMID 40258203
2023 (72), 2015 (63), 2014 (59), 2016 (56), 2018 (55), 2019 (52), 2025 (50), 2017 (46), 2009 (40), 2008 (36), 2004 (27), 2005 (15), U10EY011751 (15), U10CA180868 (6), U10CA180886 (6)